Combination Antibiotic Treatment Does Not Result in Less Organ Failure in …Newswise (press release)Among 551 evaluable patients, there was no statistically significant difference in average Sequential Organ Failure Assessment (SOFA; degree of organ f…
Landmark Sleep Apnea, Heart Failure Study Recruits 1000th ParticipantBusiness Review India (press release)SERVE-HF, the largest study to investigate if treatment of predominant central sleep apnea (CSA) improves survival and outcomes of patients with s…
Left ventricular assist devices should now be used in heart failureOnMedicaHeart failure should be managed with left ventricular assist devices (LVADs), which represent a step change in treatment, say new guidelines on the diagnosis and treatment of th…
Landmark Sleep Apnea, Heart Failure Study Recruits 1000th ParticipantMarketWatch (press release)MUNICH, May 21, 2012 /PRNewswire via COMTEX/ — SERVE-HF, the largest study to investigate if treatment of predominant central sleep apnea (CSA) improves su…
eMaxHealthNordic walking enables heart failure patients to exercise more intenselyNews-Medical.netThe research was presented at the Heart Failure Congress 2012, 19-22 May, in Belgrade, Serbia. The Congress is the main annual meeting of the Heart Failur…
Girl died of heart failure, Gwaze trial toldRadio New ZealandA medical expert has told a High Court murder trial in Christchurch that a girl died of heart failure caused by an overwhelming septic shock. Zimbabwean vet George Gwaze, 60, is on trial in r…
ESC Heart Failure Guidelines feature new recommendations on devices, drugs and …EurekAlert (press release)New recommendations on devices, drugs and diagnosis in heart failure were launched at the Heart Failure Congress 2012, 19-22 May, in Belgrade, S…
Neurocrine announces Urocortin 2 phase II study results in acute decompensated …pharmabiz.comNeurocrine Biosciences Inc., a biopharmaceutical company focused on neurological and endocrine diseases and disorders, has reported efficacy and safety resul…
Final results from C3BS-CQR-1 Phase II trial on heart failureNews-Medical.netAndré Terzic, MD, Ph.D, Director at Center of Regenerative Medicine, Mayo Clinic, the co-lead investigator on the trial, will present new final follow up data on the Company&…
SunHerald.comPositive results from CardioKinetix Parachute system study on heart failureNews-Medical.netCardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced two-year clinical results for …